FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sagent Pharmaceuticals Phenylephrine HCl Injection Recall

Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 2…

Sagent Pharmaceuticals Inc · Schaumburg, IL

Risk level
Class II
Reported by FDA
Mar 24, 2021
Recall ID
D-0305-2021
Check your lot numberHow we source this data

Summary

Sagent Pharmaceuticals recalled Phenylephrine HCl Injection starting Mar 11, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0305-2021 on Mar 24, 2021. Reason: Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.

Product description

Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.

Lot numbers, UPCs & expiration codes

Lots: PHT8IB2, PHT9IB2, exp 08/2022; PHT1JB2, exp 09/2022

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0305-2021
Classification
Class II
Status
Terminated
Recall initiated
Mar 11, 2021
FDA report date
Mar 24, 2021
Quantity
3716 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Sagent Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0305-2021, exactly as published.

Show all FDA fields
City
Schaumburg
State
IL
Status
Terminated
Country
United States
Event ID
87492
Address
1901 N Roselle Rd Ste 450
Code information
Lots: PHT8IB2, PHT9IB2, exp 08/2022; PHT1JB2, exp 09/2022
Postal code
60195-3194
Report date
Mar 24, 2021
Product type
Drugs
Recall number
D-0305-2021
Classification
Class II
Recalling firm
Sagent Pharmaceuticals Inc
Product quantity
3716 cartons
Termination date
Dec 28, 2022
Reason for recall
Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Mar 11, 2021
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 17, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0305-2021, published Mar 24, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls